| rs16825455 |
chr1 |
21837755 |
0.000009 |
A |
G |
Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs) |
ALPL |
intron |
23648065
|
| rs7535497 |
chr1 |
21840709 |
0.000643 |
T |
G |
Type 2 diabetes |
ALPL |
intron |
17463246
|
| rs7523855 |
chr1 |
21840886 |
0.000604 |
C |
T |
Type 2 diabetes |
ALPL |
intron |
17463246
|
| rs1890431 |
chr1 |
21852078 |
0.0000648 |
C |
T |
Tunica Media |
ALPL |
intron |
pha003036
|
| rs1697414 |
chr1 |
21874996 |
0.000698 |
T |
A |
Multiple complex diseases |
ALPL |
intron |
17554300
|
| rs885814 |
chr1 |
21875916 |
0.000006 |
C |
T |
Response to TNF-alpha inhibitors in rheumatoid arthritis |
ALPL |
intron |
22569225
|
| rs885813 |
chr1 |
21877074 |
0.0000349 |
C |
T |
Lactate dehydrogenase levels |
ALPL |
intron |
20981236
|
| rs3767155 |
chr1 |
21885195 |
0.000309 |
C |
T |
Alzheimer's disease |
ALPL |
intron |
24755620
|
| rs1767429 |
chr1 |
21889340 |
0.000193 |
A |
G |
Alzheimer's disease |
ALPL |
intron |
24755620
|
| rs1256335 |
chr1 |
21890386 |
0.000000000000001 |
G |
A |
Folate pathway vitamin levels |
ALPL |
intron |
19744961
|
| rs3738097 |
chr1 |
21894816 |
0.000986 |
T |
C |
Type 2 diabetes |
ALPL |
intron |
17463246
|
| rs3767142 |
chr1 |
21901558 |
0.000327 |
G |
A |
Alzheimer's disease |
ALPL |
intron |
24755620
|
| rs2242420 |
chr1 |
21904529 |
0.0000000000005 |
C |
T |
Blood cell counts and other traits |
ALPL |
UTR-3 |
20139978
|
| rs2242420 |
chr1 |
21904529 |
0.000000000000508 |
C |
T |
Blood cell counts and other traits |
ALPL |
UTR-3 |
20139978
|